ConductScience.org, home

Paper33059819

Imaging for Response Assessment in Cancer Clinical Trials.

Sorace AG and 12 others. Semin Nucl Med, 2020. Cited by 35 papers, by iCite.

Cite this record

ConductScience Library. Imaging for Response Assessment in Cancer Clinical Trials. Papers, record 33059819. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33059819

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Imaging for Response Assessment in Cancer Clinical Trials.
PubMed
Journal
Semin Nucl Med
PubMed
Year
2020
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
35
iCite
Relative citation ratio, by iCite
1.7
iCite
Revised in PubMed
2024-12-13
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sorace AGAnna G
2Elkassem AAAsser A
3Galgano SJSamuel J
4Lapi SESuzanne E
5Larimer BMBenjamin M
6Partridge SCSavannah C
7Quarles CCC Chad
8Reeves KKirsten
9Napier TSTiara S
10Song PNPatrick N
11Yankeelov TEThomas E
12Woodard SStefanie
13Smith ADAndrew D

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Clinical Trials as TopicMajor topic
NeoplasmsMajor topic
Humans
Diagnostic Imaging
Treatment Outcome

Grants10

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
U01 CA225427NCI NIH HHSUnited StatesU01CA225427PubMed and NIHNIH RePORTER
U01 CA142565NCI NIH HHSUnited StatesU01CA142565PubMed and NIHNIH RePORTER
R01 CA207290NCI NIH HHSUnited StatesR01CA207290PubMed and NIHNIH RePORTER
TL1 TR003106NCATS NIH HHSUnited StatesTL1TR003106PubMed and NIHNIH RePORTER
U24 CA226110NCI NIH HHSUnited StatesU24CA226110PubMed and NIHNIH RePORTER
R01 CA240589NCI NIH HHSUnited StatesR01CA240589PubMed and NIHNIH RePORTER
R01 CA186193NCI NIH HHSUnited StatesR01CA186193PubMed and NIHNIH RePORTER
U01 CA174706NCI NIH HHSUnited StatesU01CA174706PubMed and NIHNIH RePORTER
DP2 CA261453NCI NIH HHSUnited StatesDP2CA261453PubMedNIH RePORTER
R00 CA215604NCI NIH HHSUnited StatesR00CA215604PubMed and NIHNIH RePORTER

Download CSV of grants

References123

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128522740Initial Experience with Volumetric 68Ga-PSMA I&T PET/CT for Assessment of Whole-Body Tumor Burden as a Quantitative Imaging Biomarker in Patients with Prostate Cancer.J Nucl Med2017https://conductscience.org/library/papers/28522740PubMed
231614001Response assessment using [68 Ga]Ga-PSMA ligand PET in patients undergoing systemic therapy for metastatic castration-resistant prostate cancer.Prostate2020https://conductscience.org/library/papers/31614001PubMed
324892406Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach.Nat Commun2014https://conductscience.org/library/papers/24892406PubMed
428928380Predictors of responses to immune checkpoint blockade in advanced melanoma.Nat Commun2017https://conductscience.org/library/papers/28928380PubMed
528749202Abbreviated breast MRI for screening women with dense breast: the EA1141 trial.Br J Radiol2018https://conductscience.org/library/papers/28749202PubMed
623882093Apparent diffusion coefficient and beyond: what diffusion MR imaging can tell us about tissue structure.Radiology2013https://conductscience.org/library/papers/23882093PubMed
72887254989Zr-Trastuzumab PET/CT for Detection of Human Epidermal Growth Factor Receptor 2-Positive Metastases in Patients With Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer.Clin Nucl Med2017https://conductscience.org/library/papers/28872549PubMed
830179110Diffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter Trial.Radiology2018https://conductscience.org/library/papers/30179110PubMed
932118298Relevance of liver surface nodularity for preoperative risk assessment in patients with resectable hepatocellular carcinoma.Br J Surg2020https://conductscience.org/library/papers/32118298PubMed
1019097774New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).Eur J Cancer2009https://conductscience.org/library/papers/19097774PubMed
1127655428Inter-observer agreement improves with PERCIST 1.0 as opposed to qualitative evaluation in non-small cell lung cancer patients evaluated with F-18-FDG PET/CT early in the course of chemo-radiotherapy.EJNMMI Res2016https://conductscience.org/library/papers/27655428PubMed
1230755811Antibody and fragment-based PET imaging of CTLA-4+ T-cells in humanized mouse models.Am J Cancer Res2019https://conductscience.org/library/papers/30755811PubMed
132808243489Zr-Bevacizumab PET: Potential Early Indicator of Everolimus Efficacy in Patients with Metastatic Renal Cell Carcinoma.J Nucl Med2017https://conductscience.org/library/papers/28082434PubMed
1429975116Neuroendocrine Tumor Diagnosis and Management: 68Ga-DOTATATE PET/CT.AJR Am J Roentgenol2018https://conductscience.org/library/papers/29975116PubMed
1529570895Repeatability, reproducibility, and accuracy of quantitative mri of the breast in the community radiology setting.J Magn Reson Imaging2018https://conductscience.org/library/papers/29570895PubMed
1623572497Comparison of EORTC criteria and PERCIST for PET/CT response evaluation of patients with metastatic colorectal cancer treated with irinotecan and cetuximab.J Nucl Med2013https://conductscience.org/library/papers/23572497PubMed
1728461564Granzyme B PET Imaging as a Predictive Biomarker of Immunotherapy Response.Cancer Res2017https://conductscience.org/library/papers/28461564PubMed
1830973773Current Imaging Techniques for Noninvasive Staging of Hepatic Fibrosis.AJR Am J Roentgenol2019https://conductscience.org/library/papers/30973773PubMed
1928423698Parameters of simultaneous 18F-FDG-PET/MRI predict tumor stage and several histopathological features in uterine cervical cancer.Oncotarget2017https://conductscience.org/library/papers/28423698PubMed
2027865762Tumor-targeted nanomedicines for cancer theranostics.Pharmacol Res2017https://conductscience.org/library/papers/27865762PubMed

See all 123 referencesDownload CSV of references

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.

PMIDTitleJournalYearIn PapersSource
42938211Optimizing Portal Venous Phase Acquisition Quality of Contrast-Enhanced CT in Oncology.Diagnostics (Basel)2026https://conductscience.org/library/papers/42938211PubMed
42505404Rewiring Tumor Lifelines: Translating Hypoxia- and Pseudohypoxia-Driven Angiogenesis into Therapeutic Breakthroughs.Cells2026https://conductscience.org/library/papers/42505404PubMed
42147365Artificial intelligence empowered biomaterials for cancer therapy: From rational design to clinical translation.Chin J Cancer Res2026https://conductscience.org/library/papers/42147365PubMed
42063134Prediction of relapsed/refractory primary central nervous system lymphoma using pre-chemotherapy ITSS grade on SWI and pre-/post-chemotherapy ADC parameters on DWI.Cancer Imaging2026https://conductscience.org/library/papers/42063134PubMed
41150754Monitoring Pharmacological Treatment of Breast Cancer with MRI.Curr Issues Mol Biol2025https://conductscience.org/library/papers/41150754PubMed
40888645Modeling the effects of combination immunotherapy on triple-negative breast cancer in syngeneic mice from PET imaging of CD4+ and CD8+ cells.Math Med Biol2025https://conductscience.org/library/papers/40888645PubMed
40647404Current Approaches of Nuclear Molecular Imaging in Breast Cancer.Cancers (Basel)2025https://conductscience.org/library/papers/40647404PubMed
40635706Potential mechanisms and clinical applications of static magnetic field therapy in glioma.Front Neurol2025https://conductscience.org/library/papers/40635706PubMed
40585764Harnessing Biomarker Activatable Probes for Early Stratification and Timely Assessment of Therapeutic Efficacy in Cancer.Exploration (Beijing)2025https://conductscience.org/library/papers/40585764PubMed
40392709Comparison of Progression-Free Survival in Familial Non-Medullary Thyroid Cancer and Sporadic Differentiated Thyroid Cancer Patients.Thyroid2025https://conductscience.org/library/papers/40392709PubMed
40121305Characterizing SSTR2 expression and modulation for targeted imaging and therapy in preclinical models of triple-negative breast cancer.Sci Rep2025https://conductscience.org/library/papers/40121305PubMed
40050894Oxygen-delivery nanoparticles enhanced immunotherapy efficacy monitored by granzyme B PET imaging in malignant tumors.J Nanobiotechnology2025https://conductscience.org/library/papers/40050894PubMed
40003667Systematic Review: AI Applications in Liver Imaging with a Focus on Segmentation and Detection.Life (Basel)2025https://conductscience.org/library/papers/40003667PubMed
39941318The Value of MRI and Radiomics for the Diagnostic Evaluation of Thyroid-Associated Ophthalmopathy.Diagnostics (Basel)2025https://conductscience.org/library/papers/39941318PubMed
38338997In Vitro MRS of Cells Treated with Trastuzumab at 1.5 Tesla.Int J Mol Sci2024https://conductscience.org/library/papers/38338997PubMed
37931781Investigating tumor-host response dynamics in preclinical immunotherapy experiments using a stepwise mathematical modeling strategy.Math Biosci2023https://conductscience.org/library/papers/37931781PubMed
37626587Combination Therapy with Trastuzumab and Niraparib: Quantifying Early Proliferative Alterations in HER2+ Breast Cancer Models.Biomedicines2023https://conductscience.org/library/papers/37626587PubMed
37540134Discrepant Assessments of Progressive Disease in Clinical Trials between Routine Clinical Reads and Formal RECIST 1.1 Interpretations.Radiol Imaging Cancer2023https://conductscience.org/library/papers/37540134PubMed
37310427Patlak-Ki derived from ultra-high sensitivity dynamic total body [18F]FDG PET/CT correlates with the response to induction immuno-chemotherapy in locally advanced non-small cell lung cancer patients.Eur J Nucl Med Mol Imaging2023https://conductscience.org/library/papers/37310427PubMed
36828382Evaluation of Apparent Diffusion Coefficient Repeatability and Reproducibility for Preclinical MRIs Using Standardized Procedures and a Diffusion-Weighted Imaging Phantom.Tomography2023https://conductscience.org/library/papers/36828382PubMed

See all 29 cited byDownload CSV of cited by

Genes23

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
COL11A21302PubTator's text mininghttps://conductscience.org/library/genes/1302NCBI Gene
CTLA41493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
EREG2069PubTator's text mininghttps://conductscience.org/library/genes/2069NCBI Gene
FOLH12346PubTator's text mininghttps://conductscience.org/library/genes/2346NCBI Gene
GRPR2925PubTator's text mininghttps://conductscience.org/library/genes/2925NCBI Gene
GZMB3002PubTator's text mininghttps://conductscience.org/library/genes/3002NCBI Gene
HIF1A3091PubTator's text mininghttps://conductscience.org/library/genes/3091NCBI Gene
HK13098PubTator's text mininghttps://conductscience.org/library/genes/3098NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
KLK3354PubTator's text mininghttps://conductscience.org/library/genes/354NCBI Gene
MDM24193PubTator's text mininghttps://conductscience.org/library/genes/4193NCBI Gene
MUC1694025PubTator's text mininghttps://conductscience.org/library/genes/94025NCBI Gene
PDCD15133PubTator's text mininghttps://conductscience.org/library/genes/5133NCBI Gene
SLC2A16513PubTator's text mininghttps://conductscience.org/library/genes/6513NCBI Gene
SLC2A36515PubTator's text mininghttps://conductscience.org/library/genes/6515NCBI Gene

See all 23 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33059819

GET https://conductscience.org/api/papers/v1/33059819/references?page=2